
Open Orphan first three volunteers in the COVID-19 characterisation study have now successfully completed the quarantine phase
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced an update in the